June 2013
Volume 54, Issue 15
Free
ARVO Annual Meeting Abstract  |   June 2013
Anti-Diuretic Hormone Arginine-Vasopressin Promotes an Increased Myopic Shift in Refractive Compensation to Optical Defocus in Physiologically Stressful Environmental Light Conditions
Author Affiliations & Notes
  • Melanie Murphy
    School of Psychological Science, La Trobe University, Melbourne, VIC, Australia
  • Sheila Crewther
    School of Psychological Science, La Trobe University, Melbourne, VIC, Australia
  • Sarah Kiely
    School of Psychological Science, La Trobe University, Melbourne, VIC, Australia
  • Nina Riddell
    School of Psychological Science, La Trobe University, Melbourne, VIC, Australia
  • Loretta Giummarra
    School of Psychological Science, La Trobe University, Melbourne, VIC, Australia
  • David Crewther
    Centre for Human Psychopharmacology, Swinburne University of Technology, Melbourne, VIC, Australia
  • Footnotes
    Commercial Relationships Melanie Murphy, None; Sheila Crewther, None; Sarah Kiely, None; Nina Riddell, None; Loretta Giummarra, None; David Crewther, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 5183. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Melanie Murphy, Sheila Crewther, Sarah Kiely, Nina Riddell, Loretta Giummarra, David Crewther; Anti-Diuretic Hormone Arginine-Vasopressin Promotes an Increased Myopic Shift in Refractive Compensation to Optical Defocus in Physiologically Stressful Environmental Light Conditions. Invest. Ophthalmol. Vis. Sci. 2013;54(15):5183.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: Arginine-Vasopressin (AVP) is a naturally occurring anti-diuretic hormone that acts to control osmolarity and body fluid volume. AVP has been localized to the inner retina, reduces IOP and is associated with retinal AQP-4 expression (ARVO 2009). Thus we aimed to determine whether AVP’s anti-diuretic action would affect refraction and ocular growth compensation to optical defocus especially in the presence of asymmetric flicker, a physiologically stressful stimulus of environmental origin.

Methods: Chicks were raised from days 5-9 post-hatching in one of 3 lens (+, -10D or No Lens) and in one of 3 light conditions (a Normal Diurnal 12 hr day/night cycle or either Fast ON/Slow OFF or Fast OFF/Slow ON sawtooth flicker generated by a light emitting diode array at 1 Hz) following a single intravitreal injection of 5μl of either PBS alone or as the carrier solution for Vasopressin (1.84 x 10-4 mM) or the dual V1/V2 Vasopressin receptor antagonist ([des-Gly9-β-Mercapto-β, β-cyclopentamethylenepropionyl1, O-Et-Tyr2, Val4, Arg8]-Vasopressin) (5.53 x 10-4 mM). Retinoscopy and A-scan ultrasonography was performed on Day 9.

Results: AVP-injected, -10D lens-wearing eyes all showed a myopic shift as expected of an anti-diuretic agent in all light conditions, as did the +10D eyes reared under Fast ON flicker. In comparison, the AVP antagonist prevented the myopic shift typically induced by flicker conditions in the +10D lensed eyes. Changes in refraction were closely mirrored by changes in posterior eye growth. Significant interaction effects between drug, light and lens conditions were observed for refractive state, axial length and vitreous chamber depth, while more variable growth patterns were observed for anterior chamber depth.

Conclusions: The finding that the natural anti-diuretic hormone, AVP, but not its antagonist, increased myopia and axial elongation in the presence of negative defocus highlights the importance of the interaction between modulation of fluid dynamics and responses to light-induced environmental stress in ocular growth and refractive compensation.

Keywords: 688 retina • 605 myopia • 726 stress response  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×